|
1
|
Nana-Sinkam SP and Powell CA: Molecular
biology of lung cancer: Diagnosis and management of lung cancer,
3rd edition: American college of chest physicians evidence-based
clinical practice guidelines. Chest. 143:e30S–e39S. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Reungwetwattana T and Dy GK: Targeted
therapies in development for non-small cell lung cancer. J
Carcinog. 12:222013. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Othman N and Nagoor NH: The role of
microRNAs in the regulation of apoptosis in lung cancer and its
application in cancer treatment. Biomed Res Int. 2014:3180302014.
View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Hassan M, Watari H, AbuAlmaaty A, Ohba Y
and Sakuragi N: Apoptosis and molecular targeting therapy in
cancer. Biomed Res Int. 2014:1508452014. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Tsuruo T, Naito M, Tomida A, Fujita N,
Mashima T, Sakamoto H and Haga N: Molecular targeting therapy of
cancer: Drug resistance, apoptosis and survival signal. Cancer Sci.
94:15–21. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Ding Y and Nguyen TA: Pq1, a quinoline
derivative, induces apoptosis in T47D breast cancer cells through
activation of caspase-8 and caspase-9. Apoptosis. 18:1071–1082.
2013. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Ornitz DM and Itoh N: The fibroblast
growth factor signaling pathway. Wiley Interdiscip Rev Dev Biol.
4:215–266. 2015. View
Article : Google Scholar : PubMed/NCBI
|
|
8
|
Koul HK, Pal M and Koul S: Role of p38 MAP
kinase signal transduction in solid tumors. Genes Cancer.
4:342–359. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Chen Y, Long H, Wu Z, Jiang X and Ma L:
EGF transregulates opioid receptors through EGFR-mediated GRK2
phosphorylation and activation. Mol Biol Cell. 19:2973–2983. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Qu WS, Tian DS, Guo ZB, Fang J, Zhang Q,
Yu ZY, Xie MJ, Zhang HQ, Lu JG and Wang W: Inhibition of EGFR/MAPK
signaling reduces microglial inflammatory response and the
associated secondary damage in rats after spinal cord injury. J
Neuroinflammation. 9:1782012. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Feng W, Li HC, Xu K, Chen YF, Pan LY, Mei
Y, Cai H, Jiang YM, Chen T and Feng DX: SHCBP1 is over-expressed in
breast cancer and is important in the proliferation and apoptosis
of the human malignant breast cancer cell line. Gene. 587:91–97.
2016. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Asano E, Hasegawa H, Hyodo T, Ito S, Maeda
M, Chen D, Takahashi M, Hamaguchi M and Senga T: SHCBP1 is required
for midbody organization and cytokinesis completion. Cell Cycle.
13:2744–2751. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Buckley MW, Arandjelovic S, Trampont PC,
Kim TS, Braciale TJ and Ravichandran KS: Unexpected phenotype of
mice lacking SHCBP1, a protein induced during T cell proliferation.
PLoS One. 9:e1055762014. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Kupershmidt I, Su QJ, Grewal A, Sundaresh
S, Halperin I, Flynn J, Shekar M, Wang H, Park J, Cui W, et al:
Ontology-based meta-analysis of global collections of
high-throughput public data. PLoS One. 5(pii): e130662010.
View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Tao HC, Wang HX, Dai M, Gu CY, Wang Q, Han
ZG and Cai B: Targeting SHCBP1 inhibits cell proliferation in human
hepatocellular carcinoma cells. Asian Pac J Cancer Prev.
14:5645–5650. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Carracedo A, Alimonti A and Pandolfi PP:
PTEN level in tumor suppression: How much is too little? Cancer
Res. 71:629–633. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Hollander MC, Blumenthal GM and Dennis PA:
PTEN loss in the continuum of common cancers, rare syndromes and
mouse models. Nat Rev Cancer. 11:289–301. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Lu XX, Cao LY, Chen X, Xiao J, Zou Y and
Chen Q: PTEN inhibits cell proliferation, promotes cell apoptosis
and induces cell cycle arrest via downregulating the PI3K/AKT/hTERT
pathway in lung adenocarcinoma A549 cells. Biomed Res Int.
2016:24768422016. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Lu S, Xu J, Xu X, Hu S, Li B and Li W: The
expression of astrocyte elevated gene-1 in human non-small-cell
lung cancer and its relationship with postoperative chemotherapy
and radiotherapy. Histopathology. 67:817–826. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Chu C, Liu X, Bai X, Zhao T, Wang M, Xu R,
Li M, Hu Y, Li W, Yang L, et al: MiR-519d suppresses breast cancer
tumorigenesis and metastasis via targeting MMP3. Int J Biol Sci.
14:228–236. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Xue Y, Wu L, Liu Y, Ma Y, Zhang L, Ma X,
Yang Y and Chen J: ENTPD5 induces apoptosis in lung cancer cells
via regulating caspase 3 expression. PLoS One. 10:e01200462015.
View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Guo Y, Chang H, Li J, Xu XY, Shen L, Yu ZB
and Liu WC: Thymosin alpha 1 suppresses proliferation and induces
apoptosis in breast cancer cells through PTEN-mediated inhibition
of PI3K/Akt/mTOR signaling pathway. Apoptosis. 20:1109–1121. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Shimizu S: development of anti-cancer
drugs mediated by apoptosis and autophagy. Nihon Rinsho.
73:1302–1307. 2015.(In Japanese). PubMed/NCBI
|
|
25
|
Gali-Muhtasib H, Hmadi R, Kareh M, Tohme R
and Darwiche N: Cell death mechanisms of plant-derived anticancer
drugs: Beyond apoptosis. Apoptosis. 20:1531–1562. 2015. View Article : Google Scholar : PubMed/NCBI
|
